Radiotherapy for early mediastinal hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): The roles of intensity-modulated radiotherapy and involved-node radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 268-276

  Koeck, Julia ^a   Abo Madyan, Yasser ^a,b   Lohr, Frank ^a   Stieler, Florian ^a   Kriz, Jan ^c   Mueller, Rolf Peter ^c   Wenz, Frederik ^a   Eich, Hans Theodor ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Hodgkin lymphoma; Intensity modulated radiotherapy; Involved field; Involved node; Mediastinum

Indexed keywords

HODGKIN LYMPHOMA; INTENSITY-MODULATED RADIOTHERAPY; INVOLVED-FIELD; INVOLVED-NODE; MEDIASTINUM;

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; ONCOLOGY; PHYSICAL THERAPY; RADIOTHERAPY;

THREE DIMENSIONAL;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EARLY CANCER; FEMALE; GERMANY; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDIASTINUM CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

ALGORITHMS; BREAST; FEMALE; GERMANY; HEART; HODGKIN DISEASE; HUMANS; LUNG; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MONTE CARLO METHOD; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PRACTICE GUIDELINES AS TOPIC; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD;

EID: 84859850165     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.054     Document Type: Article

References (19)

1. A. Engert, A. Plutschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
2. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
3. G. Gagliardi, L.S. Constine, and V. Moiseenko Radiation dose-volume effects in the heart Int J Radiat Oncol Biol Phys 76 2010 77 85
4. J. Franklin, A. Pluetschow, and M. Paus Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials Ann Oncol 17 2006 1749 1760
5. M.L. De Bruin, J. Sparidans, and M.B. van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
6. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
7. T. Girinsky, C. Pichenot, and A. Beaudre Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226
8. D.C. Weber, N. Peguret, and G. Dipasquale Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
9. P. Pommier, S. Dussart, and T. Girinsky Impact of 18F-fluoro-2- deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: A prospective multicenter study Int J Radiat Oncol Biol Phys 79 2011 823 828
10. M. Shahidi, N. Kamangari, and S. Ashley Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease Radiother Oncol 78 2006 1 5
11. H.T. Eich, R. Engenhart-Cabillic, and K. Hansemann Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: An analysis of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 71 2008 1419 1424
12. H.T. Eich, R.P. Muller, and R. Engenhart-Cabillic Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG) Strahlenther Onkol 184 2008 406 410
13. O. Koelbl, T. Krieger, and U. Haedinger Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam Strahlenther Onkol 180 2004 783 788
14. H. Chen, F. Lohr, and P. Fritz Stereotactic, single-dose irradiation of lung tumors: A comparison of absolute dose and dose distribution between pencil beam and Monte Carlo algorithms based on actual patient CT scans Int J Radiat Oncol Biol Phys 78 2010 955 963
15. ICRU50 Prescribing, recording and reporting photon beam therapy. Report 50 1993 International Commission on Radiation Units and Measurements Washington, DC
16. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955
17. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
18. B.A. Campbell, N. Voss, and T. Pickles Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size J Clin Oncol 26 2008 5170 5174
19. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277